本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Mereo Biopharma Group Plc

2.53
+0.04001.61%
盘后2.530.00000.00%16:05 EST
成交量:205.11万
成交额:507.43万
市值:3.92亿
市盈率:-8.05
高:2.55
开:2.48
低:2.37
收:2.49
数据加载中...
2024/03/27

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/06

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/05

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/24

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/01/08

重要事件披露

Form 8-K - Current report
2023/11/20

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/15

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/13

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/08

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/06

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/02

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]